Peptide Tesamorelin 2mg

Tesamorelin injection is used to decrease the amount of extra fat in the stomach area in adults with human immunodeficiency virus (HIV) who have lipodystrophy (increased body fat in certain areas of the body). Tesamorelin injection is not used to help with weight loss. Tesamorelin injection is in a class of medications called human growth hormone-releasing factor (GRF) analogs. It works by increasing the production of a certain natural substance that can decrease the amount of body fat.

DOSAGE AND ADMINISTRATION

• General Dosing Information

The recommended dose of Tesamorelin is 2 mg injected subcutaneously once a day.

The recommended injection site is the abdomen. Injection sites should be rotated to different areas of the abdomen. Do not inject into scar tissue, bruises or the navel.

• Administration

Reconstituted Tesamorelin solution should always be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Tesamorelin must be injected only if the solution is clear, colorless and without particulate matter.

Tesamorelin should be injected subcutaneously into the skin on the abdomen. Injection sites should be rotated to different areas of the abdomen. Do not inject into scar tissue, bruises or the navel.

Dosage Forms and Strengths

Tesamorelin for injection is supplied in a vial containing 2 mg of tesamorelin as a lyophilized powder. The diluent (Sterile Water for Injection, 10 mL) is provided in a separate vial.

Tesamorelin for injection is supplied as a sterile, white to off-white lyophilized powder. Each single-use vial of tesamorelin contains 2 mg of tesamorelin as the free base ( 2.2 mg tesamorelin acetate, anhydrous) and the following inactive ingredient: 100 mg mannitol, USP.

After reconstitution with Sterile Water for Injection, the reconstituted solution concentration is 1mg/mL and should be injected immediately.